Skip to Main Content

Author Details

Mary Carrington
Frederick National Laboratory for Cancer Research, National Cancer Institute
1985
425
102
PMIDPaper TitleJournal TitlePublished Year
36596305Progressive transformation of the HIV-1 reservoir cell profile over two decades of antiviral therapy.Cell Host Microbe2023
35639875Risk Factors for Ebola Virus Persistence in Semen of Survivors in Liberia.Clin Infect Dis2023
36449053Distinct frequency patterns of LILRB3 and LILRA6 allelic variants in Europeans.Immunogenetics2023
37670157Author Correction: Africa-specific human genetic variation near CHD1L associates with HIV-1 load.Nature2023
37662332Insights into the Mechanisms and Structure of Breakage-Fusion-Bridge Cycles in Cervical Cancer using Long-Read Sequencing.medRxiv2023
37732256Understanding the heterogeneity of alloreactive natural killer cell function in kidney transplantation.bioRxiv2023
36909546Mass spectrometric profiling of HLA-B44 peptidomes provides evidence for tapasin-mediated tryptophan editing.bioRxiv2023
37034605Viral and Host Mediators of Non-Suppressible HIV-1 Viremia.medRxiv2023
36707444Comparison between qPCR and RNA-seq reveals challenges of quantifying HLA expression.Immunogenetics2023
37264229HLA class I signal peptide polymorphism determines the level of CD94/NKG2-HLA-E-mediated regulation of effector cell responses.Nat Immunol2023
37454979HLA-DP on Epithelial Cells Enables Tissue Damage by NKp44<sup>+</sup> Natural Killer Cells in Ulcerative Colitis.Gastroenterology2023
36877848HIV post-treatment controllers have distinct immunological and virological features.Proc Natl Acad Sci U S A2023
36695358Host variation in type I interferon signaling genes (MX1), C-C chemokine receptor type 5 gene, and major histocompatibility complex class I alleles in treated HIV+ noncontrollers predict viral reservoir size.AIDS2023
37532928Africa-specific human genetic variation near CHD1L associates with HIV-1 load.Nature2023
36596305Progressive transformation of the HIV-1 reservoir cell profile over two decades of antiviral therapy.Cell Host Microbe2023
37670157Author Correction: Africa-specific human genetic variation near CHD1L associates with HIV-1 load.Nature2023
37662332Insights into the Mechanisms and Structure of Breakage-Fusion-Bridge Cycles in Cervical Cancer using Long-Read Sequencing.medRxiv2023
37732256Understanding the heterogeneity of alloreactive natural killer cell function in kidney transplantation.bioRxiv2023
37532928Africa-specific human genetic variation near CHD1L associates with HIV-1 load.Nature2023
35639875Risk Factors for Ebola Virus Persistence in Semen of Survivors in Liberia.Clin Infect Dis2023
37454979HLA-DP on Epithelial Cells Enables Tissue Damage by NKp44<sup>+</sup> Natural Killer Cells in Ulcerative Colitis.Gastroenterology2023
37034605Viral and Host Mediators of Non-Suppressible HIV-1 Viremia.medRxiv2023
37264229HLA class I signal peptide polymorphism determines the level of CD94/NKG2-HLA-E-mediated regulation of effector cell responses.Nat Immunol2023
36449053Distinct frequency patterns of LILRB3 and LILRA6 allelic variants in Europeans.Immunogenetics2023
36695358Host variation in type I interferon signaling genes (MX1), C-C chemokine receptor type 5 gene, and major histocompatibility complex class I alleles in treated HIV+ noncontrollers predict viral reservoir size.AIDS2023
36877848HIV post-treatment controllers have distinct immunological and virological features.Proc Natl Acad Sci U S A2023
36909546Mass spectrometric profiling of HLA-B44 peptidomes provides evidence for tapasin-mediated tryptophan editing.bioRxiv2023
36707444Comparison between qPCR and RNA-seq reveals challenges of quantifying HLA expression.Immunogenetics2023
34781719A Possible Sterilizing Cure of HIV-1 Infection Without Stem Cell Transplantation.Ann Intern Med2022
35906236Mouse fetal growth restriction through parental and fetal immune gene variation and intercellular communications cascade.Nat Commun2022
36099881NKG2A and HLA-E define an alternative immune checkpoint axis in bladder cancer.Cancer Cell2022
35835913Genetic regulation of OAS1 nonsense-mediated decay underlies association with COVID-19 hospitalization in patients of European and African ancestries.Nat Genet2022
35364034T cell reactivity to the SARS-CoV-2 Omicron variant is preserved in most but not all individuals.Cell2022
35862190Herpes simplex virus lymphadenitis is associated with tumor reduction in a patient with chronic lymphocytic leukemia.J Clin Invest2022
35858580Immune correlates of HIV-1 reservoir cell decline in early-treated infants.Cell Rep2022
35858344Genetic variation that determines <i>TAPBP</i> expression levels associates with the course of malaria in an HLA allotype-dependent manner.Proc Natl Acad Sci U S A2022
34581306Robust HIV-specific CD4+ and CD8+ T-cell responses distinguish elite control in adolescents living with HIV from viremic nonprogressors.AIDS2022
34781719A Possible Sterilizing Cure of HIV-1 Infection Without Stem Cell Transplantation.Ann Intern Med2022
35202566T cell reactivity to the SARS-CoV-2 Omicron variant is preserved in most but not all individuals.Cell2022
35019948Association of Cutaneous Immune-Related Adverse Events With Increased Survival in Patients Treated With Anti-Programmed Cell Death 1 and Anti-Programmed Cell Death Ligand 1 Therapy.JAMA Dermatol2022
34895481HLA-A*03 and response to immune checkpoint blockade in cancer: an epidemiological biomarker study.Lancet Oncol2022
35090584Trans-ancestral fine-mapping of MHC reveals key amino acids associated with spontaneous clearance of hepatitis C in HLA-DQβ1.Am J Hum Genet2022
35223535Natural Killer Cell Receptors and Ligands Are Associated With Markers of HIV-1 Persistence in Chronically Infected ART Suppressed Patients.Front Cell Infect Microbiol2022
35835913Genetic regulation of OAS1 nonsense-mediated decay underlies association with COVID-19 hospitalization in patients of European and African ancestries.Nat Genet2022
35858344Genetic variation that determines <i>TAPBP</i> expression levels associates with the course of malaria in an HLA allotype-dependent manner.Proc Natl Acad Sci U S A2022
35364034T cell reactivity to the SARS-CoV-2 Omicron variant is preserved in most but not all individuals.Cell2022
35862190Herpes simplex virus lymphadenitis is associated with tumor reduction in a patient with chronic lymphocytic leukemia.J Clin Invest2022
35858580Immune correlates of HIV-1 reservoir cell decline in early-treated infants.Cell Rep2022
35906236Mouse fetal growth restriction through parental and fetal immune gene variation and intercellular communications cascade.Nat Commun2022
36099881NKG2A and HLA-E define an alternative immune checkpoint axis in bladder cancer.Cancer Cell2022
  • 1 - 50 of 850

Recommended Authors

University of California San Francisco
Career Start Year 2012
Number of shared co-authors 13
The Rockefeller University
Career Start Year 2010
Number of shared co-authors 6
Aaron Diamond AIDS Research Center, Columbia University Irving Medical Center
Career Start Year 2008
Number of shared co-authors 0
University of California San Francisco
Career Start Year 2008
Number of shared co-authors 9
LEO Pharma
Career Start Year 2007
Number of shared co-authors 6
Hannover Medical School
Career Start Year 2004
Number of shared co-authors 11
Benaroya Research Institute at Virginia Mason
Career Start Year 2003
Number of shared co-authors 1
University Hospital and University of Lausanne
Career Start Year 2001
Number of shared co-authors 8
Rollins School of Public Health, Emory University
Career Start Year 2001
Number of shared co-authors 7
Center for Infectious Medicine, Karolinska Institutet
Career Start Year 2000
Number of shared co-authors 3
The University of Texas at Austin
Career Start Year 2000
Number of shared co-authors 2
University of California San Francisco
Career Start Year 1999
Number of shared co-authors 6
Center for Translational Immunology, Benaroya Research Institute at Virginia Mason
Career Start Year 1998
Number of shared co-authors 2
University of Texas Southwestern Medical Center
Career Start Year 1998
Number of shared co-authors 5
Medical University of Graz
Career Start Year 1996
Number of shared co-authors 10
California Pacific Medical Center Research Institute
Career Start Year 1996
Number of shared co-authors 5
Lausanne University Hospital
Career Start Year 1994
Number of shared co-authors 12
University of Massachusetts Medical School
Career Start Year 1994
Number of shared co-authors 31
Center for Systems Immunology, Benaroya Research Institute
Career Start Year 1993
Number of shared co-authors 1
University of Oklahoma Health Sciences Center
Career Start Year 1990
Number of shared co-authors 22
London School of Hygiene and Tropical Medicine
Career Start Year 1989
Number of shared co-authors 13
University of California san francisco
Career Start Year 1988
Number of shared co-authors 7
Center for Translational Immunology, Benaroya Research Institute at Virginia Mason
Career Start Year 1982
Number of shared co-authors 12
National Center for Global Health and Medicine
Career Start Year 1979
Number of shared co-authors 18
Universidade de Santiago de Compostela
Career Start Year 1979
Number of shared co-authors 1
University of Chicago
Career Start Year 1978
Number of shared co-authors 14
University of Washington
Career Start Year 1976
Number of shared co-authors 37
Universite de Strasbourg
Career Start Year 1976
Number of shared co-authors 5
Wash Benaroya Research Institute at Virginia Mason
Career Start Year 1975
Number of shared co-authors 14
Vanderbilt University Medical Center
Career Start Year 1973
Number of shared co-authors 32

Collaborators

Co-authored papers 77
Ragon Institute of Mass General
Co-authored papers 58
Co-authored papers 54
Co-authored papers 35
Co-authored papers 33
National Cancer Institute
Co-authored papers 28
Ecole Polytechnique Federale de Lausanne
Co-authored papers 25
University of California san francisco
Co-authored papers 25
Co-authored papers 24
Co-authored papers 22
Johns Hopkins Bloomberg School of Public Health
Co-authored papers 21
Northwestern University Feinberg School of Medicine
Co-authored papers 20
Co-authored papers 20
Johns Hopkins University
Co-authored papers 19
Co-authored papers 19
Institute for Genomic Medicine, Columbia University Irving Medical Center
Co-authored papers 17
Vir Biotechnology Inc.
Co-authored papers 16
Massachusetts General Hospital/Harvard Medical School
Co-authored papers 16
Frederick National Laboratory
Co-authored papers 16
Co-authored papers 15
Co-authored papers 14
Co-authored papers 14
Co-authored papers 13
Co-authored papers 13
Co-authored papers 13
Co-authored papers 12
National Cancer Institute
Co-authored papers 12
Co-authored papers 11
Ragon Institute of MGH
Co-authored papers 11
Co-authored papers 10